· Published by Health Canada · Official notice
| Brand | Lot | Product Name | Market Authorization | Dosage Form | Strength |
|---|---|---|---|---|---|
| PMS-AMITRIPTYLINE 50 mg | 634972 635465 637195 637532 | PMS-AMITRIPTYLINE 50 mg | DIN 00654507 | Tablet | Amitriptyline Chlorhydrate 50 mg |
| PMS-AMITRIPTYLINE 10 mg | 635484 638600 636906 636907 648428 648429 633439 632625 632626 633440 636905 636146 636749 634973 635485 | PMS-AMITRIPTYLINE 10 mg | DIN 00654523 | Tablet | Amitriptyline Chlorhydrate 10 mg |
| PMS-AMITRIPTYLINE 25 mg | 635435 633433 632775 635482 | PMS-AMITRIPTYLINE 25 mg | DIN 00654515 | Tablet | Amitriptyline Chlorhydrate 25 mg |
Affected lots exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT) or exceed the acceptable cumulative intake limit for (N-nitrosodimethylamine (NDMA) and NNORT).